Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$74,434,501
+$13,801,893 QoQ
Shares Held
3,343,868
+47.3% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. ACAD ranks #15 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,434,501 | 3,343,868 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $60,632,608 | 2,270,034 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,466,863 | 1,943,152 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $52,509,490 | 2,434,376 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $39,340,153 | 2,368,462 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $49,547,293 | 2,700,125 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $32,695,942 | 2,125,874 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $33,610,200 | 2,068,320 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $30,486,275 | 1,648,798 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,647,482 | 1,777,307 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $33,943,796 | 1,628,781 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $59,981,457 | 2,504,445 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $51,086,607 | 2,714,485 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,887,187 | 2,882,361 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $47,768,909 | 2,919,860 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $30,592,799 | 2,171,242 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $56,484,769 | 2,332,154 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $78,256,289 | 3,352,883 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $43,226,910 | 2,602,463 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $71,331,896 | 2,924,637 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $40,689,721 | 1,577,121 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $86,742,912 | 1,622,576 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $70,831,653 | 1,717,131 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $68,839,420 | 1,420,248 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $60,685,745 | 1,436,349 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||